ReST Therapeutics

View the org chart displaying its 7 main executives

Most searched biographies at ReST Therapeutics

• Gilles Rubinstenn, Chief Executive Officer and Chief Scientific Of...
• Philippe Guerret, Director
• Patrick Tricoli, Director

Create your alert
to follow the executive moves at ReST Therapeutics.

ReST Therapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by ReST Therapeutics

Social media about ReST Therapeutics

• ReST Therapeutics on Wikipedia, Google News & Yahoo Finance
• ReST Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Thierry Timsit

Call ReST Therapeutics at +33 46...

View the org chart

Register to receive your alert

Report an error